View in EDS

A Novel Molecular Signature for Early-Stage Squamous Cell Carcinoma of the Lung Predicting Locoregional Recurrence Following Local Therapy With Surgery or Stereotactic Body Radiation Therapy (SBRT).

Saved in:
Bibliographic Details
Title: A Novel Molecular Signature for Early-Stage Squamous Cell Carcinoma of the Lung Predicting Locoregional Recurrence Following Local Therapy With Surgery or Stereotactic Body Radiation Therapy (SBRT).
Authors: Kim, S.1, Chen, D.1, Al-Rashdan, A.F.2, Elsaka, R.3, Torres-Roca, J.1, Haura, E.1, Dilling, T.J.1, Robinson, L.1, Stevens, C.4
Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS78-S78. 1p.
Subjects: Lung cancer treatment, Squamous cell carcinoma, Tumor classification, Cancer relapse, Stereotactic radiotherapy, Oncologic surgery
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2014.05.458